The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AG-K-89298     3-(2-aminoethyl)cyclohexa- 2,4-diene-1,6-dione

Synonyms: CHEBI:74684, HMDB12219, SureCN12023988, AC1Q6BWP, CTK4J2981, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Dopamine quinone


High impact information on Dopamine quinone

  • Instead, we provide evidence that COX-2 inhibition prevents the formation of the oxidant species dopamine-quinone, which has been implicated in the pathogenesis of PD [2].
  • Striatal dopaminergic neurons showed increased susceptibility to oxidative stress by H(2)O(2), responding with enhanced release of DA and with formation of an unidentified metabolite, which is most likely the toxic dopamine quinone (DAQ) [3].
  • One of the potential targets in brain for dopamine quinone damage is tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis [4].
  • Mechanistic studies of melanogenesis: the influence of N-substitution on dopamine quinone cyclization [5].

Associations of Dopamine quinone with other chemical compounds


  1. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Asanuma, M., Miyazaki, I., Ogawa, N. Neurotoxicity research. (2003) [Pubmed]
  2. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Teismann, P., Tieu, K., Choi, D.K., Wu, D.C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., Przedborski, S. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  3. Increased sensitivity of striatal dopamine release to H2O2 upon chronic rotenone treatment. Milusheva, E., Baranyi, M., Kittel, A., Sperlágh, B., Vizi, E.S. Free Radic. Biol. Med. (2005) [Pubmed]
  4. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase. Xu, Y., Stokes, A.H., Roskoski, R., Vrana, K.E. J. Neurosci. Res. (1998) [Pubmed]
  5. Mechanistic studies of melanogenesis: the influence of N-substitution on dopamine quinone cyclization. Borovansky, J., Edge, R., Land, E.J., Navaratnam, S., Pavel, S., Ramsden, C.A., Riley, P.A., Smit, N.P. Pigment Cell Res. (2006) [Pubmed]
  6. Chromatographic analysis of dopamine metabolism in a Parkinsonian model. Baranyi, M., Milusheva, E., Vizi, E.S., Sperlágh, B. Journal of chromatography. A. (2006) [Pubmed]
WikiGenes - Universities